Abstract
Background: Chronic myeloid leukemia (CML) is considered a type of hematopoietic stem cell disease that affects the bone marrow and blood.
Objective: This study aimed to investigate the possible role of the Periplaneta americana extract CII-3 (PAE CII-3) in the aging of K562 cells.
Materials and Methods: The proliferation and cell cycle of K562 cells were determined using the CCK-8 assay and the cell cycle assay, respectively. K562 cells were stained with SA-β-Gal to evaluate cell aging. The mitochondrial membrane potential of K562 cells was detected with the JC-1 mitochondrial membrane potential assay kit. Telomerase activity was verified using the PCR assay. The transcription of silencing information regulator 2 related enzyme 1 (SIRT1), TSC2, and the mTOR gene were evaluated with RT-PCR assay. The expression of SIRT1, p-TSC2, and p-mTOR was examined using a Western blot assay.
Results: PAE CII-3 at all concentrations (5, 10, 20, 40, 80, 160 µg/mL) demonstrated obvious inhibitory effects on K562 cell proliferation, among which 80 µg/mL showed the highest inhibitory effect. PAE CII-3 significantly blocked the cell cycle and reduced the colony-forming unit (CFU) of K562 cells compared to those in the Control group (p < 0.001). PAE CII-3 markedly increased positive SA-β-Gal staining K562 cells compared to the Control group (p < 0.001). PAE CII-3 significantly reduced mitochondrial membrane potential and decreased TERT gene transcription in K562 cells compared to those of the Control group (p < 0.001). The transcription of the SIRT1 gene (p < 0.01) and the TCS2 gene (p < 0.001) was markedly decreased, and the transcription of the mTOR gene (p < 0.05) was significantly increased in K562 cells treated with PAE CII-3 compared to those of the Control group. PAE CII-3 significantly decreased the expression of SIRT1 (p < 0.01) and p-TSC2 (p < 0.001) and upregulated the expression of p-mTOR (p < 0.01) in K562 cells compared to those of the Control group.
Conclusion: PAE CII-3 treatment could trigger aging in K562 cells by activating the SIRT1/TSC2/mTOR signaling pathway. This study would provide a potential hypothesis of the mechanism by which PAE CII-3 treatment induces the aging of chronic myeloid leukemia cells.
[http://dx.doi.org/10.3892/or.2021.8087] [PMID: 34036393]
[http://dx.doi.org/10.3390/ijms23020749] [PMID: 35054935]
[http://dx.doi.org/10.1155/2021/5580288] [PMID: 34211630]
[http://dx.doi.org/10.1186/s12943-018-0780-6]
[http://dx.doi.org/10.3390/ijms232315004] [PMID: 36499332]
[http://dx.doi.org/10.3390/ijms22020659] [PMID: 33440869]
[http://dx.doi.org/10.1056/NEJMoa1902328] [PMID: 31826340]
[http://dx.doi.org/10.3389/fimmu.2020.609705] [PMID: 33552068]
[http://dx.doi.org/10.3390/molecules27144416] [PMID: 35889289]
[http://dx.doi.org/10.3389/fphar.2022.995523] [PMID: 36278177]
[http://dx.doi.org/10.1590/s0102-865020200100000002] [PMID: 33237174]
[http://dx.doi.org/10.1155/2021/6659154] [PMID: 33777160]
[http://dx.doi.org/10.1016/j.biopha.2019.108858] [PMID: 30986622]
[PMID: 31746373]
[http://dx.doi.org/10.3892/etm.2020.8810] [PMID: 32765665]
[http://dx.doi.org/10.12659/MSM.920666] [PMID: 32253370]
[http://dx.doi.org/10.1073/pnas.1722020115] [PMID: 29666270]
[http://dx.doi.org/10.1186/s13020-017-0149-6] [PMID: 28919922]
[http://dx.doi.org/10.1016/j.jep.2021.114884] [PMID: 34999145]
[http://dx.doi.org/10.4014/jmb.2104.04040] [PMID: 34409948]
[http://dx.doi.org/10.1038/nrc.2016.138] [PMID: 28127048]
[http://dx.doi.org/10.1073/pnas.92.20.9363] [PMID: 7568133]
[http://dx.doi.org/10.1016/j.arr.2015.04.002]
[http://dx.doi.org/10.1016/j.bbrc.2015.10.139] [PMID: 26522222]
[http://dx.doi.org/10.7754/Clin.Lab.2020.200835] [PMID: 33978360]
[PMID: 28721811]
[http://dx.doi.org/10.12659/MSM.918207] [PMID: 32037392]
[http://dx.doi.org/10.1159/000484629] [PMID: 29190625]
[http://dx.doi.org/10.1038/s41419-021-04157-x] [PMID: 34556628]
[http://dx.doi.org/10.1007/s13311-019-00753-0] [PMID: 31420820]